Searched for
DR RAHUL PURWAR
Homegrown cell, gene therapy pioneer ImmunoACT turns profitable in first year of opsImmunoAct, an Indian cell and gene therapy company, has achieved profitability in its first full year, generating ₹62 crore in revenue and ...- CDSCO approves India's first CAR-T cell therapy against certain blood cancersIndian company ImmunoACT, backed by drug maker Laurus Labs, has received approval from the Central Drugs Standard Control Organization for ...
- Seeking technology, manufacturing partnership with Indian pharma companies, says Mexico foreign secretaryThe Mexican government has partnered with ImmunoAct, an IIT Bombay-incubated company which is developing cutting-edge chimeric antigen rece...
- Laurus Labs to buy 26% in CAR T-cell therapy companyFounded in 2018 by Dr Rahul Purwar and a team of scientists, ImmunoACT is collaborating with institutions like Tata Memorial Hospital. Carl...
- Laurus Labs acquires stake in IIT-Bombay incubated CAR-T cell therapy companyAs per the agreement, Laurus will acquire 26.62% stake (fully diluted basis) for a cash consideration of approximately Rs 46 crores, subjec...
Load More